VARILRIX subst sèche c solv ser pré 0.5 ml

7680005850034 CH-585 J07BK01 08.08.
VARILRIX subst sèche c solv ser pré 0.5 ml
VARILRIX subst sèche c solv ser pré 0.5 ml
VARILRIX subst sèche c solv ser pré 0.5 ml
1 / 3
google

Details

Product number
0058501
CPT
-
Packaging group
1 x 1
Unit
Kombipackung(en)
Composition
Vaccinum attenuatum: virus varicellae vivus (Stamm: OKA) min. 10^3.3 U., lactosum, sorbitolum 6 mg, mannitolum, aminoacida, phenylalaninum 331 µg, residui: neomycini sulfas, pro vitro. Solvens: aqua ad iniectabile 0.5 ml, pro vitro.

Articles (1)

Varilrix, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Pulver
1 x 1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
12/09/2025
Professional SmPC
Français
12/09/2025
Professional SmPC
Italien
12/09/2025

Detailed composition

Substance Quantity Type Category
VACA
- Substance Wirkstoff (Principe actif)
SOLV
0.5 ML Substance HNIDK
VACA
- Substance HNIDK
VACA
6.0 MG Substance HBESI
VACA
- Substance HNIDK
VACA
- Substance HNIDK
VACA
331.0 UG Substance HBESI
VACA
- Substance HNIDK

Reimbursement information

Public price
CHF 61.35
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2005

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
585
Drug name
Varilrix, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Galenic form
PULMJ
ATC Code
J07BK01
Authorization status
Z
Dispensation category
B
First authorization
19/12/1995
Authorization expiration date
31/12/9999
IT number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Varizellen, ab dem vollendeten 9. Lebensmonat

Packaging details

Description (FR)
VARILRIX subst sèche c solv ser pré 0.5 ml
Description (DE)
VARILRIX Trockensub c Solv Fertspr 0.5 ml
Market launch
19/12/1998
Narcotic (BTM)
No

Application methods

SUBC

Other packaging sizes